Pro-Dex Stock (NASDAQ:PDEX)


RevenueOwnershipFinancialsChart

Previous Close

$61.98

52W Range

$23.47 - $68.99

50D Avg

$57.05

200D Avg

$43.17

Market Cap

$200.89M

Avg Vol (3M)

$33.41K

Beta

-0.00

Div Yield

-

PDEX Company Profile


Pro-Dex, Inc. focuses on the development and manufacturing of advanced motorized surgical instruments. These sophisticated tools are supplied globally to original equipment manufacturers (OEMs) in the medical device sector. Their product portfolio features versatile, autoclavable (sterilization-friendly) surgical drivers and shavers, available in both battery-powered and electric models, often equipped with multi-functional capabilities. These instruments are primarily employed in orthopedic, thoracic, and craniomaxillofacial surgical procedures. Beyond its core manufacturing, Pro-Dex also offers expert consulting services, covering engineering, quality assurance, and regulatory compliance. Furthermore, the company manufactures and distributes rotary air motors to various industrial clients. Founded in 1978, Pro-Dex, Inc. maintains its corporate headquarters in Irvine, California.

Show More

Industry

Medical - Instruments & Supplies

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

146

IPO Date

Aug 07, 1986

Website

PDEX Performance


PDEX Financial Summary


Jun 25Jun 24Jun 23
Revenue$66.59M$53.84M$46.09M
Operating Income$10.69M$7.17M$5.76M
Net Income$8.98M$2.13M$7.07M
EBITDA$14.13M$4.35M$6.62M
Basic EPS$2.73$0.61$1.98
Diluted EPS$2.67$0.60$1.95

Fiscal year ends in Jun 25 | Currency in USD

Latest Earnings Call Transcripts


Q1 15Nov 13, 14 | 4:30 PM
Q4 14Sep 18, 14 | 4:30 PM
Q3 14May 12, 14 | 4:30 PM

Peer Comparison


TickerCompany
MBOTMicrobot Medical Inc.
RPIDRapid Micro Biosystems, Inc.
GLSIGreenwich LifeSciences, Inc.
TVGNTevogen Bio Holdings Inc.
APYXApyx Medical Corporation
CGTXCognition Therapeutics, Inc.
SERASera Prognostics, Inc.
STSSSkyAI, Inc.
LUCDLucid Diagnostics Inc.
IXHLIncannex Healthcare Limited